Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 38 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 21 | 882+2.3%/yr | +2.3%/yr | 4.21.5× | 2% | 1,290 in 2030+6.6%/yr |
| Decompression & minimally invasive spine |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 23 |
| 876−1.5%/yr |
| −1.5%/yr |
| 4.21.3× |
| 1% |
| 1,130 in 2030+4.3%/yr |
| Cervical fusion & disc arthroplasty | 8 | 341−3.9%/yr | −3.9%/yr | 1.61.3× | 0% | 450 in 2030+4.8%/yr |
| Kyphoplasty & vertebroplasty | 3 | 261−4.7%/yr | −4.7%/yr | 1.31.4× | 0% | 490 in 2030+11%/yr |
| SI joint fusion | 2 | 102+43%/yr | +43%/yr | 0.52.1× | 0% | 170 in 2030+8.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 72 | 13,119−1.8%/yr | −1.8%/yr | 61.60.6× | 42% | 19,400 in 2030+6.7%/yr |
| Skin substitutes & wound grafts | 11 | 2,190+7.1%/yr | +7.1%/yr | 6.80.5× | 51% | 4,080 in 2030+11%/yr |
| Bone graft & orthobiologics | 4 | 149−11%/yr | −11%/yr | 0.70.9× | 1% | 200 in 2030+5.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 27 | 2,085+4.8%/yr | +4.8%/yr | 9.81.0× | 42% | 3,470 in 2030+8.9%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 4 | 403+11%/yr | +11%/yr | 1.82.0× | 20% | 790 in 2030+12%/yr |
| Spinal cord & DRG stimulation | 7 | 175−2.7%/yr | −2.7%/yr | 0.81.3× | 46% | 200 in 2030+1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 5 | 646+5.1%/yr | +5.1%/yr | 3.00.6× | 47% | 4,230 in 2030+37%/yr |
| Dialysis access | 7 | 518−3.1%/yr | −3.1%/yr | 2.60.5× | 0% | 510 in 2030−0.2%/yr |
| Superficial venous ablation | 7 | 286−4.7%/yr | −4.7%/yr | 1.30.2× | 72% | 300 in 2030+1.1%/yr |
| Thrombectomy, IVC filters & venous stents | 2 | 265+6.5%/yr | +6.5%/yr | 1.31.1× | 0% | 360 in 2030+5.1%/yr |
| Carotid revascularization | 7 | 243+15%/yr | +15%/yr | 1.21.5× | 0% | 590 in 2030+16%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 14 | 1,085−3%/yr | −3%/yr | 5.60.9× | 1% | 1,430 in 2030+4.7%/yr |
| Cholecystectomy & appendectomy | 14 | 858−2.1%/yr | −2.1%/yr | 4.31.2× | 0% | 1,150 in 2030+5%/yr |
| Colorectal resection | 0 | 307−1.1%/yr | −1.1%/yr | 1.51.1× | 0% | 320 in 2030+0.6%/yr |
| Antireflux & hiatal hernia surgery | 4 | 195−6.6%/yr | −6.6%/yr | 1.01.4× | 0% | 260 in 2030+4.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 17 | 1,020−1.6%/yr | −1.6%/yr | 5.01.1× | 38% | 1,180 in 2030+2.4%/yr |
| Kidney stone management | 20 | 895−1%/yr | −1%/yr | 4.41.2× | 21% | 1,470 in 2030+8.6%/yr |
| Hysterectomy, hysteroscopy & ablation | 5 | 440+2.5%/yr | +2.5%/yr | 2.41.0× | 9% | 690 in 2030+7.8%/yr |
| Incontinence, prolapse & sacral neuromodulation | 4 | 408+1.3%/yr | +1.3%/yr | 2.01.1× | 11% | 900 in 2030+14%/yr |
| Prostatectomy & nephrectomy | 5 | 276+4.7%/yr | +4.7%/yr | 1.51.2× | 0% | 260 in 2030−1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 5 | 636+0.2%/yr | +0.2%/yr | 3.20.7× | 67% | 930 in 2030+6.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 12 | 906−4.7%/yr | −4.7%/yr | 4.70.7× | 5% | 1,220 in 2030+5.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 36 | 3,935+37%/yr | +37%/yr | 19.00.9× | 46% | 8,300 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 16 | 883+3.2%/yr | +3.2%/yr | 4.51.1× | 0% | 1,260 in 2030+6.1%/yr |
| LAA occlusion & loop recorders | 16 | 740+15%/yr | +15%/yr | 3.21.2× | 0% | 1,470 in 2030+12%/yr |
| EP ablation | 10 | 646+5.8%/yr | +5.8%/yr | 2.70.9× | 0% | 1,310 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 23 | 908−8.2%/yr | −8.2%/yr | 3.70.8× | 0% | 1,170 in 2030+4.3%/yr |
| Structural heart (TAVR, TEER) | 17 | 257+2.2%/yr | +2.2%/yr | 1.10.7× | 0% | 530 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 39 | 9,223+0.2%/yr | +0.2%/yr | 44.50.9× | 99% | 11,200 in 2030+3.3%/yr |
| Vitreoretinal surgery | 6 | 497+2.3%/yr | +2.3%/yr | 2.50.9× | 77% | 620 in 2030+3.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 83 | 19,523−0.2%/yr | −0.2%/yr | 99.40.9× | 37% | 27,700 in 2030+6%/yr |
| ERCP & endoscopic ultrasound | 12 | 559+4.8%/yr | +4.8%/yr | 2.80.8× | 0% | 1,080 in 2030+12%/yr |
| Bronchoscopy & lung nodule | 5 | 286+3%/yr | +3%/yr | 1.40.6× | 0% | 650 in 2030+15%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.